NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Indoco Remedies Limited (NSE: INDOCO)
INDOCO Technical Analysis
5
As on 28th Mar 2024 INDOCO SHARE Price closed @ 328.65 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 344.35 & Strong Sell for SHORT-TERM with Stoploss of 356.93 we also expect STOCK to react on Following IMPORTANT LEVELS. |
INDOCOSHARE Price
Open | 337.85 | Change | Price | % |
High | 338.80 | 1 Day | -5.25 | -1.57 |
Low | 327.45 | 1 Week | -7.75 | -2.30 |
Close | 328.65 | 1 Month | -22.45 | -6.39 |
Volume | 75404 | 1 Year | 2.55 | 0.78 |
52 Week High 415.35 | 52 Week Low 309.35 |
NSE INDIA Most Active Stocks
IDEA | 13.25 | -0.38% |
IDFCFIRSTB | 75.40 | -3.08% |
YESBANK | 23.20 | 0.22% |
GTLINFRA | 1.60 | 0.00% |
NHPC | 89.70 | 0.96% |
TATASTEEL | 155.85 | 2.06% |
BCG | 13.80 | -1.08% |
MAHABANK | 62.35 | 5.41% |
IRFC | 142.35 | -0.35% |
SOUTHBANK | 27.25 | -1.80% |
NSE INDIA Top Gainers Stocks
GOCLCORP | 454.60 | 19.99% |
NRL | 90.70 | 15.32% |
AEGISCHEM | 446.65 | 13.18% |
VIPIND | 525.50 | 12.89% |
REPRO | 834.35 | 12.02% |
GENESYS | 591.45 | 10.91% |
ONELIFECAP | 30.25 | 10.00% |
IFBIND | 1505.95 | 9.98% |
WEIZMANIND | 110.85 | 9.97% |
OMAXE | 90.55 | 9.96% |
NSE INDIA Top Losers Stocks
PERSISTENT | 3984.55 | -50.81% |
SITINET | 0.55 | -8.33% |
RACE | 325.10 | -6.35% |
RACE | 325.10 | -6.35% |
FCONSUMER | 0.75 | -6.25% |
KHANDSE | 29.35 | -6.23% |
CAMLINFINE | 89.25 | -6.10% |
ORIENTBELL | 347.15 | -6.06% |
KOHINOOR | 38.75 | -5.95% |
DWARKESH | 69.50 | -5.89% |
INDOCO Daily Charts |
INDOCO Intraday Charts |
Whats New @ Bazaartrend |
INDOCO Free Analysis |
|
INDOCO Important Levels Intraday
RESISTANCE | 350.52 |
RESISTANCE | 343.51 |
RESISTANCE | 339.17 |
RESISTANCE | 334.84 |
SUPPORT | 322.46 |
SUPPORT | 318.13 |
SUPPORT | 313.79 |
SUPPORT | 306.78 |
INDOCO Target March 2024
4th UP Target | 473.36 |
3rd UP Target | 439.99 |
2nd UP Target | 419.36 |
1st UP Target | 398.73 |
1st DOWN Target | 339.87 |
2nd DOWN Target | 319.24 |
3rd DOWN Target | 298.61 |
4th DOWN Target | 265.24 |
INDOCO Weekly Target
4th UP Target | 380.95 |
3rd UP Target | 366.15 |
2nd UP Target | 357.00 |
1st UP Target | 347.85 |
1st DOWN Target | 321.75 |
2nd DOWN Target | 312.60 |
3rd DOWN Target | 303.45 |
4th DOWN Target | 288.65 |
INDOCO Target2024
4th UP Target | 621.62 |
3rd UP Target | 549.01 |
2nd UP Target | 504.12 |
1st UP Target | 459.24 |
1st DOWN Target | 331.16 |
2nd DOWN Target | 286.28 |
3rd DOWN Target | 241.39 |
4th DOWN Target | 168.78 |
Indoco Remedies Limited ( NSE INDIA Symbol : INDOCO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
INDOCO Synopsis Technicals View
50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
RSI (14) | RSI is 34.62 | Sideways | |
MFI (14) | MFI is 59.05 | Sideways | |
CCI (20) | CCI is Below -100 | Over Sold | |
WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
PSAR | Stoploss For Long Buy | 222.40 | |
10 Day Avg Volume | Traded -20.67 % Less then 10 Day Average Volume |
INDOCO Other Details
Segment | EQ | |
Market Capital | 43734581248.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
INDOCO Address
INDOCO Latest News
INDOCO Business Profile
Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastrointestinal products, such as Carmicide, Cyclopam, Cyclomeff, and Nosic; pain/analgesics products that include Lignox and T-lac; and ophthal/otologicals products, such as Renolen, Homide, Dexoren ? S, Zincoren, Otorex, Mofloren-D, and Mofloren LP. It also provides vitamins/minerals/nutrients that include Methycal, Cital UTI, SM Fibro, Cal Aid, SM Fibro, MCBM DHA, and Apispur; urology products, such as Carmicide and Cital; Cloben G and Scabex for dermatology; ATM for anti-infectives; Hemsyl for blood related; MCBM 69 and D Chiro for gynecological; and Spear for anti-haemorrhoidal. In addition, the company provides analytical services, such as impurity profile, particle size analysis, heavy metal analysis, polymorphism and compatibility studies, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, it offers services that include architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. The company serves general practitioners, pediatricians, consultant physicians, dentists, cardiologists, diabetologists, endocrinologists, gynaecologists, and ophthalmologists. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India. Address: Indoco House, Mumbai, India, 400098
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service